Antidepressants and benzodiazepines for major depression

0
This evidence summary presents the best available evidence regarding the efficacy and safety of a combination of antidepressants and benzodiazepines for adults with major...

ICYMI: the latest in pharmacy

0
If you need to catch up on all the happenings in pharmacy post-break, Australian Pharmacist has you covered.

How to manage neuropathic pain

0
Neuropathic pain is defined as ‘pain caused by a lesion or disease of the somatosensory nervous system’.1 It is associated with impaired quality of...

Long COVID: managing the after-effects

0
Some people who are infected with COVID-19 do not recover quickly. They live with the aftermath – long COVID – a multi-system condition that we must start learning how to manage, including pharmacists.

Q&A: CPD planning

0
PSA has developed a CPD planning tool available free to members, that intuitively helps pharmacists through each of the required steps.

The science of safety

0
All about PSA Lifetime Fellow Dr John McEwen’s evolution from pharmacy apprentice to international authority on pharmacovigilance.